- Home
- NERV vs YMAT Comparison
NERV vs YMAT Comparison
Compare NERV & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- YMAT
- Stock Information
- Founded
- NERV 2007
- YMAT 1970
- Country
- NERV United States
- YMAT Taiwan
- Employees
- NERV N/A
- YMAT N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- YMAT Recreational Games/Products/Toys
- Sector
- NERV Health Care
- YMAT Consumer Discretionary
- Exchange
- NERV Nasdaq
- YMAT Nasdaq
- Market Cap
- NERV 14.6M
- YMAT 17.4M
- IPO Year
- NERV 2014
- YMAT 2025
- Fundamental
- Price
- NERV $4.78
- YMAT $1.00
- Analyst Decision
- NERV Hold
- YMAT
- Analyst Count
- NERV 1
- YMAT 0
- Target Price
- NERV $5.00
- YMAT N/A
- AVG Volume (30 Days)
- NERV 9.3M
- YMAT 1.3M
- Earning Date
- NERV 11-05-2025
- YMAT 11-09-2025
- Dividend Yield
- NERV N/A
- YMAT N/A
- EPS Growth
- NERV N/A
- YMAT N/A
- EPS
- NERV 1.48
- YMAT 0.07
- Revenue
- NERV N/A
- YMAT $17,563,985.00
- Revenue This Year
- NERV N/A
- YMAT N/A
- Revenue Next Year
- NERV N/A
- YMAT N/A
- P/E Ratio
- NERV $3.06
- YMAT $12.25
- Revenue Growth
- NERV N/A
- YMAT N/A
- 52 Week Low
- NERV $1.15
- YMAT $0.80
- 52 Week High
- NERV $12.46
- YMAT $6.45
- Technical
- Relative Strength Index (RSI)
- NERV 63.84
- YMAT N/A
- Support Level
- NERV $4.27
- YMAT N/A
- Resistance Level
- NERV $12.46
- YMAT N/A
- Average True Range (ATR)
- NERV 0.86
- YMAT 0.00
- MACD
- NERV 0.16
- YMAT 0.00
- Stochastic Oscillator
- NERV 24.84
- YMAT 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About YMAT J-Star Holding Co. Ltd. Ordinary Shares
J Star Holding Co Ltd is engaged in the research, development and manufacturing of carbon fiber for a wide variety of products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products.